PROVIRON

This brand name is authorized in Nigeria. It is also authorized in Brazil, Ecuador, Israel, Mexico, South Africa, Spain, Turkey.

Active ingredients

The drug PROVIRON contains one active pharmaceutical ingredient (API):

1	Mesterolone UNII 0SRQ75X9I9 - MESTEROLONE
	Read more about Mesterolone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-1300	Tablet	Proviron 25 mg Tablet TAB 25 mg 2 x 10's (in Alu/PVC blisters)	White tablets	23/02/2023

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PROVIRON Tablet	MPI, EU: SmPC	Web Search

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03BB01	Mesterolone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03B Androgens → G03BB 5-androstanon (3) derivatives
Discover more medicines within G03BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	538912050016213
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.590-03-07
ES	Centro de información online de medicamentos de la AEMPS	48881
IL	מִשְׂרַד הַבְּרִיאוּת	134
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	70645
NG	Registered Drug Product Database	04-1300
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546010042
ZA	Health Products Regulatory Authority	B/21.7/137